Status:
RECRUITING
Cervical Myelopathy in Hip Fracture Patients
Lead Sponsor:
Indiana University
Conditions:
Cervical Myelopathy
Hip Fractures
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy ...
Detailed Description
Cervical myelopathy is compression of the cervical spinal cord which causes many things, but a common and prominent symptom is poor coordination/balance. This has been shown in multiple high quality s...
Eligibility Criteria
Inclusion
- Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall.
Exclusion
- Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.)
- Syncopal fall or fall caused by stroke or a heart condition
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 20 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06893406
Start Date
May 1 2025
End Date
March 20 2026
Last Update
October 31 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University North Hospital
Fishers, Indiana, United States, 46032
2
Eskenazi Hospital
Indianapolis, Indiana, United States, 46202
3
Indiana University Health Methodist Hospital
Indianapolis, Indiana, United States, 46202